Levy B I, Poitevin P, Duriez M, Guez D C, Schiavi P D, Safar M E
INSERM (U 141), Lariboisière Hospital, Paris, France.
J Hypertens. 1997 Mar;15(3):251-8. doi: 10.1097/00004872-199715030-00006.
Reduction in sodium intake improves the survival of stroke-prone spontaneously hypertensive rats (SHR-SP) without causing any change in their blood pressure.
To investigate whether the diuretic indapamide improves survival of SHR-SP and whether changes in the structure and the function of large arteries are associated with survival.
Forty-eight hypertensive rats aged 6 weeks were divided into three groups: a control SHR-SP group (n = 24) and a control spontaneously hypertensive rat (SHR) group (n = 12), with 1% saline drinking water; and an indapamide-treated SHR-SP group (n = 12) with 1% saline drinking water administered 1 mg/kg per day indapamide via their food. At the end of a 12-week follow-up period, pulsatile changes in blood pressure and common carotid artery diameter (measured by high-resolution echo-tracking techniques) were determined and aortic histomorphometry was performed.
By the end of the study 58% of the SHR-SP control group rats had died. There were no deaths in the other two groups. In these two groups the mean blood pressure (217+/-10 and 212+/-7 mmHg), carotid diameter and distensibility (0.48+/-0.09 and 0.61+/-0.22 mmHg[-1]), arterial thickness (116+/-4 and 116+/-3 microm), and collagen content of the arterial wall were identical. In the SHR-SP control group the mean blood pressure was significantly lower (168+/-9 mmHg), the carotid distensibility was higher (1.47+/-0.35 mmHg[-1]), and the arterial thickness (138+/-5 microm) and collagen content were substantially higher than those in the other two groups. In the study population as a whole, for a given mean arterial pressure the carotid distensibility was identical in the three groups, although the arterial thickness was substantially greater in the SHR-SP control group rats.
The study provides evidence that the diuretic compound indapamide improved the survival of SRH-SP even though their blood pressure was higher than that of untreated animals, and that genetic sensitivity to sodium, rather than blood pressure, influences the changes in arterial structure.
降低钠摄入量可提高易中风自发性高血压大鼠(SHR-SP)的存活率,且不会引起其血压的任何变化。
研究利尿剂吲达帕胺是否能提高SHR-SP的存活率,以及大动脉结构和功能的变化是否与存活率相关。
将48只6周龄的高血压大鼠分为三组:SHR-SP对照组(n = 24)和自发性高血压大鼠(SHR)对照组(n = 12),饮用1%盐水;吲达帕胺治疗的SHR-SP组(n = 12),通过食物给予1%盐水并每天给予1 mg/kg吲达帕胺。在12周的随访期结束时,测定血压和颈总动脉直径的搏动变化(通过高分辨率回声跟踪技术测量),并进行主动脉组织形态学测量。
到研究结束时,SHR-SP对照组中有58%的大鼠死亡。其他两组无死亡。在这两组中,平均血压(217±10和212±7 mmHg)、颈动脉直径和扩张性(0.48±0.09和0.61±0.22 mmHg[-1])、动脉厚度(116±4和116±3微米)以及动脉壁胶原含量相同。在SHR-SP对照组中,平均血压显著较低(168±9 mmHg),颈动脉扩张性较高(1.47±0.35 mmHg[-1]),动脉厚度(138±5微米)和胶原含量明显高于其他两组。在整个研究人群中,对于给定的平均动脉压,三组的颈动脉扩张性相同,尽管SHR-SP对照组大鼠的动脉厚度明显更大。
该研究提供了证据表明,利尿剂吲达帕胺提高了SRH-SP的存活率,尽管其血压高于未治疗动物,并且对钠的遗传敏感性而非血压影响动脉结构的变化。